Barclays downgraded shares of Sonova (OTCMKTS:SONVY – Free Report) from a strong-buy rating to a hold rating in a report published on Wednesday,Zacks.com reports.
A number of other analysts have also weighed in on the stock. The Goldman Sachs Group raised shares of Sonova to a “strong sell” rating in a research report on Tuesday, October 22nd. UBS Group raised Sonova to a “hold” rating in a research note on Tuesday, August 13th.
Read Our Latest Report on SONVY
Sonova Trading Up 1.6 %
About Sonova
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Featured Stories
- Five stocks we like better than Sonova
- Canadian Penny Stocks: Can They Make You Rich?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Which Wall Street Analysts are the Most Accurate?
- MarketBeat Week in Review – 11/18 – 11/22
- What is an Earnings Surprise?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.